Simplex Trading’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16.7K | Sell |
5,247
-21,430
| -80% | -$87K | ﹤0.01% | 7267 |
|
|
2026
Q1 | $118K | Buy |
26,677
+2,015
| +8% | +$10.9K | ﹤0.01% | 4897 |
|
|
2025
Q4 | $157K | Buy |
24,662
+264
| +1% | +$1.84K | ﹤0.01% | 4478 |
|
|
2025
Q3 | $227K | Buy |
+24,398
| New | +$246K | ﹤0.01% | 4786 |
|
|
2025
Q2 | – | Sell |
-2,291
| Closed | -$22.6K | – | 9976 |
|
|
2025
Q1 | $15K | Buy |
+2,291
| New | +$14.4K | ﹤0.01% | 6819 |
|
|
2024
Q4 | – | Sell |
-10,533
| Closed | -$57.7K | – | 9859 |
|
|
2024
Q3 | $38K | Buy |
10,533
+1,229
| +13% | +$3.87K | ﹤0.01% | 6151 |
|
|
2024
Q2 | $25K | Buy |
+9,304
| New | +$31.1K | ﹤0.01% | 6719 |
|
|
2024
Q1 | – | Sell |
-553
| Closed | -$1.02K | – | 10127 |
|
|
2023
Q4 | $0 | Buy |
+553
| New | +$770 | ﹤0.01% | 10047 |
|
|
2023
Q3 | – | Sell |
-28,873
| Closed | -$45.1K | – | 10067 |
|
|
2023
Q2 | $45K | Buy |
28,873
+19,503
| +208% | +$29.1K | ﹤0.01% | 5952 |
|
|
2023
Q1 | $14K | Sell |
9,370
-789
| -8% | -$1.41K | ﹤0.01% | 7276 |
|
|
2022
Q4 | $17K | Sell |
10,159
-4,156
| -29% | -$6.59K | ﹤0.01% | 7056 |
|
|
2022
Q3 | $17K | Sell |
14,315
-13,891
| -49% | -$22.4K | ﹤0.01% | 7716 |
|
|
2022
Q2 | $47K | Buy |
28,206
+18,703
| +197% | +$36.6K | ﹤0.01% | 6597 |
|
|
2022
Q1 | $23K | Buy |
9,503
+793
| +9% | +$2.17K | ﹤0.01% | 8118 |
|
|
2021
Q4 | $32K | Buy |
8,710
+2,497
| +40% | +$13.5K | ﹤0.01% | 7828 |
|
|
2021
Q3 | $60K | Sell |
6,213
-3,001
| -33% | -$24.7K | ﹤0.01% | 7309 |
|
|
2021
Q2 | $90K | Sell |
9,214
-13,269
| -59% | -$116K | ﹤0.01% | 6883 |
|
|
2021
Q1 | $209K | Buy |
+22,483
| New | +$178K | ﹤0.01% | 4679 |
|
|
2020
Q1 | – | Sell |
-71
| Closed | -$273 | – | 8418 |
|
|
2019
Q4 | $0 | Buy |
+71
| New | +$252 | ﹤0.01% | 8095 |
|
|
2019
Q3 | – | Sell |
-1,200
| Closed | -$5.12K | – | 8013 |
|
|
2019
Q2 | $5K | Buy |
+1,200
| New | +$5.12K | ﹤0.01% | 6487 |
|
|
2018
Q4 | – | Sell |
-3,264
| Closed | -$14K | – | 7968 |
|
|
2018
Q3 | $14K | Buy |
+3,264
| New | +$14K | ﹤0.01% | 6245 |
|
|
2017
Q3 | – | Sell |
-822
| Closed | -$3K | – | 6795 |
|
|
2017
Q2 | $3K | Buy |
+822
| New | +$2.6K | ﹤0.01% | 5066 |
|
|
2016
Q3 | – | Sell |
-252
| Closed | -$1K | – | 6576 |
|
|
2016
Q2 | $1K | Buy |
+252
| New | +$1.19K | ﹤0.01% | 5486 |
|
Other funds holding NAGE
SW
TCM
Simplex Trading's NAGE Position: Q2 2026 in Review
Simplex Trading reduced its Niagen Bioscience (NAGE) stake by 80% in Q2 2026, selling an estimated $87K and leaving 5,247 shares worth $16.7K. The position accounts for ﹤0.01% of the portfolio, ranked #7267.
Simplex Trading first reported a position in NAGE in Q2 2016 and has held it in 23 quarters since. The position peaked at $227K in Q3 2025. 139 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.
- Simplex Trading held 5,247 shares of Niagen Bioscience worth $16.7K as of Q2 2026.
- Simplex Trading sold 21,430 Niagen Bioscience shares in Q2 2026, an estimated $87K.
- Niagen Bioscience made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #7267 holding.
- Simplex Trading first reported a position in Niagen Bioscience in Q2 2016 and has held it in 23 quarters since.
- Simplex Trading's Niagen Bioscience position peaked at $227K in Q3 2025.
- 139 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.